First Time Loading...

Solasia Pharma KK
TSE:4597

Watchlist Manager
Solasia Pharma KK Logo
Solasia Pharma KK
TSE:4597
Watchlist
Price: 27 JPY Market Closed
Updated: May 13, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

2.2B
-2%
Assets
Growth Rates:
1 Year
-29%
3 Years
-61%
5 Years
-71%
7 Years
-40%
10 Years
-
354m
-3%
Liabilities
Growth Rates:
1 Year
-25%
3 Years
-83%
5 Years
-45%
7 Years
+30%
10 Years
-
1.9B
-2%
Equity
Growth Rates:
1 Year
-30%
3 Years
-49%
5 Years
-74%
7 Years
-45%
10 Years
-

Balance Sheet Decomposition
Solasia Pharma KK

2.2B
Assets
354m
Liabilities
2.2B
Assets
354m
Liabilities
Current Assets 976m
Cash & Short-Term Investments 728m
Receivables 67m
Other Current Assets 181m
Non-Current Assets 1.3B
Long-Term Investments 6m
PP&E 81m
Intangibles 1.1B
Other Non-Current Assets 49m
Current Liabilities 293m
Accounts Payable 213m
Other Current Liabilities 80m
Non-Current Liabilities 61m
Long-Term Debt 27m
Other Non-Current Liabilities 34m

Balance Sheet
Solasia Pharma KK

Rotate your device to view
Balance Sheet
Currency: JPY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
501
2 100
1 039
3 370
4 046
4 116
2 964
714
803
728
Cash Equivalents
501
2 100
1 039
3 370
4 046
4 116
2 964
714
803
728
Total Receivables
13
13
2
19
193
10
173
126
572
67
Accounts Receivables
0
0
0
5
145
4
77
87
542
67
Other Receivables
0
0
0
14
48
6
96
39
30
0
Inventory
0
0
68
93
122
3
4
0
14
122
Other Current Assets
9
12
15
43
143
173
128
54
46
59
Total Current Assets
523
2 125
1 123
3 525
4 504
4 302
3 269
894
1 435
976
PP&E Net
1
2
1
1
58
112
102
120
63
81
PP&E Gross
1
2
1
1
58
112
102
120
63
0
Accumulated Depreciation
2
3
4
4
9
18
31
41
40
0
Intangible Assets
1 349
1 987
2 575
3 085
3 123
3 485
2 356
2 079
1 570
1 117
Long-Term Investments
0
0
0
0
0
0
0
0
11
6
Other Long-Term Assets
5
5
5
43
43
47
48
51
55
49
Total Assets
1 879
N/A
4 119
+119%
3 705
-10%
6 655
+80%
7 728
+16%
7 946
+3%
5 775
-27%
3 144
-46%
3 134
0%
2 229
-29%
Liabilities
Accounts Payable
0
0
0
0
0
0
987
386
1
213
Accrued Liabilities
6
11
20
27
30
32
36
36
26
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
41
1 039
47
37
33
Other Current Liabilities
159
150
207
385
589
852
17
20
343
47
Total Current Liabilities
165
161
227
412
619
925
2 079
489
407
293
Long-Term Debt
1 321
2 867
0
0
0
27
21
37
0
27
Deferred Income Tax
130
63
43
34
11
65
11
18
53
22
Other Liabilities
9
29
1
1
11
12
12
13
12
12
Total Liabilities
1 625
N/A
3 120
+92%
272
-91%
447
+64%
641
+44%
1 029
+61%
2 123
+106%
557
-74%
472
-15%
354
-25%
Equity
Common Stock
1 872
2 572
4 053
5 963
7 632
960
1 402
2 110
1 436
1 596
Retained Earnings
3 428
4 072
4 546
5 554
7 975
1 400
2 717
5 201
220
1 336
Additional Paid In Capital
1 810
2 500
3 929
5 802
7 483
4 630
5 043
5 738
1 500
1 657
Treasury Stock
0
0
0
0
48
70
70
70
70
69
Other Equity
0
1
3
2
5
3
6
10
16
27
Total Equity
254
N/A
999
+294%
3 433
+244%
6 209
+81%
7 087
+14%
6 917
-2%
3 652
-47%
2 587
-29%
2 662
+3%
1 875
-30%
Total Liabilities & Equity
1 879
N/A
4 119
+119%
3 705
-10%
6 655
+80%
7 728
+16%
7 946
+3%
5 775
-27%
3 144
-46%
3 134
0%
2 229
-29%
Shares Outstanding
Common Shares Outstanding
58
71
65
88
105
116
123
134
168
174

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.